NCT00742599View on ClinicalTrials.gov

Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

July 31, 2009

Conditions
Patients Undergoing Gastric Endoscopy
Interventions
DRUG

NPO-11

20 ml NPO-11

DRUG

Placebo

20 ml NPO-11(Placebo)

Trial Locations (2)

Unknown

Kansai

Kanto

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY

NCT00742599 - Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy | Biotech Hunter | Biotech Hunter